Projected Income Statement: Procter & Gamble Company

Forecast Balance Sheet: Procter & Gamble Company

Forecast Balance Sheet - Procter & Gamble Company
Fiscal Period: June 2022 2023 2024 2025 2026 2027 2028 2029
Net Debt 1 24,279 26,361 22,978 24,952 24,196 25,670 24,326 22,143
Change - 8.58% -12.83% 8.59% -3.03% 6.09% -5.24% -8.97%
Announcement Date 29/07/22 28/07/23 30/07/24 29/07/25 29/07/26 - - -
1USD in Million
Estimates

Cash Flow Forecast: Procter & Gamble Company

Fiscal Period: June 2022 2023 2024 2025 2026 2027 2028 2029
CAPEX 1 3,156 3,062 3,322 3,773 4,409 4,497 4,179 4,199
Change - -2.98% 8.49% 13.58% 16.86% 1.99% -7.07% 0.49%
Free Cash Flow (FCF) 1 13,567 13,786 16,524 14,606 15,147 15,427 16,804 18,036
Change - 1.61% 19.86% -11.61% 3.7% 1.85% 8.92% 7.33%
Announcement Date 29/07/22 28/07/23 30/07/24 29/07/25 29/07/26 - - -
1USD in Million
Estimates

Forecast Financial Ratios: Procter & Gamble Company

Fiscal Period: June 2022 2023 2024 2025 2026 2027 2028 2029

Profitability

        
EBITDA Margin (%) 25.71% 25.42% 27.23% 27.65% 27.18% 27.31% 27.83% 28.02%
EBIT Margin (%) 22.21% 22.11% 23.78% 24.27% 23.55% 23.57% 23.98% 24.18%
EBT Margin (%) 22.44% 22.38% 22.32% 23.93% 23.41% 22.94% 23.76% 23.89%
Net margin (%) 18.38% 17.87% 17.7% 18.95% 18.44% 18.21% 18.9% 18.97%
FCF margin (%) 16.92% 16.81% 19.66% 17.33% 17.4% 17.18% 18.15% 18.8%
FCF / Net Income (%) 92.03% 94.08% 111.06% 91.44% 94.4% 94.36% 96% 99.09%

Profitability

        
ROA 12.47% 12.31% 13.39% 12.9% 12.75% 12.73% 13.15% 13.47%
ROE 31.53% 31.2% 30.48% 31.06% 30.11% 30.27% 31.21% 31.67%

Financial Health

        
Leverage (Debt/EBITDA) 1.18x 1.26x 1x 1.07x 1.02x 1.05x 0.94x 0.82x
Debt / Free cash flow 1.79x 1.91x 1.39x 1.71x 1.6x 1.66x 1.45x 1.23x

Capital Intensity

        
CAPEX / Current Assets (%) 3.94% 3.73% 3.95% 4.48% 5.07% 5.01% 4.51% 4.38%
CAPEX / EBITDA (%) 15.31% 14.69% 14.52% 16.19% 18.64% 18.34% 16.21% 15.62%
CAPEX / FCF (%) 23.26% 22.21% 20.1% 25.83% 29.11% 29.15% 24.87% 23.28%

Items per share

        
Cash flow per share 1 6.586 6.783 8.029 7.259 8.073 8.154 9.208 9.508
Change - 2.99% 18.37% -9.58% 11.21% 1.01% 12.92% 3.26%
Dividend per Share 1 3.523 3.681 3.829 4.076 4.259 4.403 4.603 4.823
Change - 4.47% 4.02% 6.47% 4.48% 3.37% 4.56% 4.77%
Book Value Per Share 1 19.57 19.8 20.45 21.3 22.42 23.72 24.84 26.25
Change - 1.18% 3.28% 4.15% 5.24% 5.78% 4.73% 5.69%
EPS 1 5.81 5.9 6.02 6.51 6.62 6.832 7.345 7.712
Change - 1.55% 2.03% 8.14% 1.69% 3.2% 7.51% 5%
Nbr of stocks (in thousands) 23,99,297 23,56,969 23,60,135 23,44,542 23,28,599 23,17,783 23,17,783 23,17,783
Announcement Date 29/07/22 28/07/23 30/07/24 29/07/25 29/07/26 - - -
1USD
Estimates
2027 *2028 *
P/E 24.7x 23x
PBR 7.11x 6.79x
EV / Sales 4.64x 4.48x
Yield 2.61% 2.73%

EPS & Dividend

EPS & Dividend - Procter & Gamble Company


Y-o-Y evolution of P/E

Valuation ratios - P/E - Procter & Gamble Company
 

Year-on-year evolution of the Yield

Valuation ratios - Yield - Procter & Gamble Company
Trader
Investor
Global
Quality
ESG MSCI
AA
MarketScreener Ratings - Procter & Gamble Company
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
168.66USD
Average target price
174.04USD
Spread / Average Target
+3.19%
  1. Stock Market
  2. Stocks
  3. PG Stock
  4. Financials Procter & Gamble Company